dependence

Also found in: Dictionary, Thesaurus, Medical, Legal, Idioms, Wikipedia.

dependence

[di′pen·dəns]

(medicine)

Habituation to, abuse of, or addiction to a substance.

(statistics)

The existence of a relationship between frequencies obtained from two parts of an experiment which does not arise from the direct influence of the result of the first part on the chances of the second part but indirectly from the fact that both parts are subject to influences from a common outside factor.

References in periodicals archive ?

Hythiam researches, develops, licenses and commercializes innovative physiological, nutritional and behavioral treatment protocols that seek to address substance dependence.

European Patent Office Provides Notification of Intention to Grant Hythiam Patent for Treatment of Cocaine Dependence

Of particular interest to us is the fact that if proven successful, the PROMETA protocol for substance dependence is an out-patient delivery which can provide us with much needed immediate expanded capacity for both probation and diversion programs.

Hythiam's Alcohol, Methamphetamine and Cocaine Treatment Protocols to Be Evaluated for Use by Texas Probation, Corrections, and Re-Entry Programs

The clinical data from this study will be used to support the further development of XR-NTX for the treatment of opioid dependence, a serious chronic brain disease.

Alkermes Announces Positive Data from Exploratory Study of Extended-Release Naltrexone for Blockade of Opioid Effect

According to the Substance Abuse and Mental Health Services Administration (SAMHSA), substance dependence costs employers $81 billion in lost productivity each year and studies have shown that substance dependent workers function at about 67% of their capacity.

Horizon Blue Cross Blue Shield of New Jersey to Conduct Commercial Evaluation of Hythiam's PROMETA(R) Protocols

Jeffrey Wilkins of Cedars-Sinai Hospital is conducting an open-label investigation of PROMETA for the treatment of alcohol dependence which he will follow up with a double-blind placebo-controlled study of PROMETA for alcohol dependence.

Acute and Immediate Impact of Hythiam's PROMETA(R) Protocols on Cravings and Cognition to Be Evaluated in Additional Double-Blind Placebo-Controlled Studies

Probuphine is designed to provide continuous, long-term therapeutic levels of the drug buprenorphine, an approved agent for the treatment of opioid dependence.

Titan Initiates Phase III Development Program for Probuphine(R) in the Treatment of Opioid Dependence

NASDAQ:HYTM), a healthcare services management company that licenses the PROMETA([R]) treatment protocols designed to treat alcohol, methamphetamine and cocaine dependence, announced today that its PROMETA protocol for stimulant dependence will be evaluated for use and adoption in Fulton County, Georgia.

Georgia's Fulton County to Evaluate Hythiam's PROMETA(R) Protocol for Stimulant Dependent Criminal Justice Population

The Pierce County Alliance (PCA) today reported at the 2006 Pacific Rim Meth Summit results from its 6 month follow up on a pilot to evaluate the PROMETA([R]) protocol for the treatment of methamphetamine and cocaine dependence within the felony and family drug court system.

Pierce County Alliance Announced 6 Months Outcomes Data on Offenders Treated with PROMETA(R) Treatment Protocol for Stimulant Dependence at 2006 Pacific Rim Meth Summit

Phase 1/2 Clinical Trial Initiated for New Alcohol Dependence Product Candidate

Alkermes Expands Addiction Franchise to Include Development Program for Oral Products

NASDAQ:HYTM), a healthcare services management company that licenses the PROMETA([R])treatment protocols designed to treat alcohol, methamphetamine and cocaine dependence, announced today that the PROMETA protocols have been licensed for use initially at up to four locations of the largest outpatient substance dependence providers in Massachusetts, Preventive Medicine Associates (PMA).

Largest Addiction Outpatient Treatment Provider in Massachusetts Becomes First in the State to Offer Hythiam's PROMETA(R) Protocols

NASDAQ:HYTM), a healthcare services management company that licenses the PROMETA(TM) treatment protocols designed to treat alcohol, methamphetamine and cocaine dependence, announced today that the Instituto Mexicano de la Propiedad Industrial has granted Hythiam a notice of allowance for a patent for the use of a composition of matter for the treatment of cocaine dependence.

Mexico Grants Hythiam Notice of Allowance for Its Patent for the Treatment of Cocaine Dependence

NASDAQ:HYTM), a healthcare services management company that licenses the PROMETA(TM) treatment protocols designed to treat alcohol, methamphetamine and cocaine dependence, announced today that the European Patent Office has granted to Hythiam a patent for a use of a composition of matter for the treatment of alcohol dependence under European Patent Number 1374952.

European Patent Office Grants Hythiam Patent for Treatment of Alcohol Dependence